Carbamazepine hypersensitivity: Progress toward predicting the unpredictable

Epilepsy Currents

Volumn 11, Issue 6, 2011, Pages 189-191

  Gidal, Barry E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; HLA A ANTIGEN; HLA B ANTIGEN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN;

ALLELE; ASIAN; BLISTER; CHINESE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRESS SYNDROME; EUROPE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HIGH RISK PATIENT; HLA TYPING; HUMAN; HYPERSENSITIVITY REACTION; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; NOTE; PATIENT IDENTIFICATION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN DISEASE; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

EID: 84859781431     PISSN: 15357597     EISSN: 15357511     Source Type: Journal    
DOI: 10.5698/1535-7511-11.6.189     Document Type: Note

References (16)

1. Arif H, Buchsbaum R, Weintraub D, Koyfman S, Salas-Hume C, Bazil CW, Resor SR, Hirsch LJ.. Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology. 2007;68:1701-1709.
2. Zaccra G, Franciotta D, Perucca E. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia. 2007;48:1223-1244.
3. Shirzadi M, Alvestad S, Hovdal H, Espeset K, Lydersen S, Brodtkorb E. Comparison of carbamazepine rash in multiple sclerosis and epilepsy. Acta Neurol Scand: DOI: 10.1111/j.1600-0404.2011.01553.x. © 2011 John Wiley & Sons.
4. Beghi E, Shorvon S. Antiepileptic drugs and the immune system. Epilepsia. 2011;52(suppl):40-44.
5. Rzany B, Correia O, Kelly P, Naldi L, Auquier A, Stern R. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during the first weeks of antiepileptic therapy: A case-control study. Lancet. 1999;353:2190-2194.
6. Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology. 2005;64:1134-1138.
7. Man CB, Kwan P, Baum L,Yu E, Lau KM, Cheng AS, Ng MH. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia. 2007;48:1015-1018.
8. Lim KS, Kwan P, Tan CT. Association of HLA-B*1502 allele and carbamazepine-induced severe adverse cutaneous drug reactions among Asians: A review. Neurol Asia. 2008;13:15-21.
9. Pei Chen, Ph.D., Juei-Jueng Lin, M.D., Chin-Song Lu, M.D., Cheung-Ter Ong, M.D., Peiyuan F. Hsieh, M.D., Chih-Chao Yang, M.D., Chih-Ta Tai, M.D., Shey-Lin Wu, M.D., Cheng-Hsien Lu, M.D., Yung-Chu Hsu, M.D., Hsiang-Yu Yu, M.D., Long-Sun Ro, M.D., Chung-Ta Lu, M.D., Chun-Che Chu, M.D., Jing-Jane Tsai, M.D., Yu-Hsiang Su, M.D., Sheng-Hsing Lan, M.D., Sheng-Feng Sung, M.D., Shu-Yi Lin, M.S., Hui-Ping Chuang, B.S., Li-Chen Huang, B.S., Ying-Ju Chen, M.S., Pei-Joung Tsai, M.S., Hung-Ting Liao, M.S., Yu-Hsuan Lin, M.S., Chien-Hsiun Chen, Ph.D., Wen-Hung Chung, M.D., Ph.D., Shuen-Iu Hung, Ph.D., Jer-Yuarn Wu, Ph.D., Chi-Feng Chang, Ph.D., Luke Chen, Ph.D., Yuan-Tsong Chen, M.D., Ph.D., and Chen-Yang Shen, Ph.D. for the Taiwan SJS Consortium 10.
10. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med. 2011;364:1126-1132.
11. Chung W-H, Hung S-I. Genetic markers and danger signals in Stevens-Johnson syndrome and toxic epidermal necrolysis. Allergol Int. 2010;59:325-332.
12. Kashiwagi M, Aihara M, Takahashi Y, Yamazaki E, Yamane Y, Song Y, Muramatsu M, Ikezawa Z . Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients. J Dermatol. 2008;35:683-685.
13. Hung SI, Chung WH, Liu ZS, Chen CH, Hsish MS, Hui RC, Chu CY, Chen YT. Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Pharmacogenomics. 2010;11:349-356.
14. Kazeem GR, Cox C, Aponte J, Messenheimer J, Brazell C, Nelsen AC, Nelson MR, Foot E. High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients. Pharmacogenet Genomics. 2009;19:661-665.
15. An DM, Wu X-T, Hu F-Y, Yan B, Stefan H, Zhou D. Association study of lamotrigine-induced cutaneous adverse reactions and HLA-B*1502 in a Han Chinese population. Epilepsy. Res 2010;92:226-230.
16. Shi Y-W, MIN F-L, Liu X-R, Ran Z-X, Gao N-M, Yu M-J, Liao WP. HLA-B alleles and lamotrigine-induced cutaneous adverse drug reactions in Han Chinese population. Basic and Clinical Pharmacology and Toxicology. 2011; 109:42-46.